In the wake of Puma Biotechnology, Inc.'s (NASDAQ:PBYI) latest US$17m market cap drop, institutional owners may be forced to take severe actions - Simply Wall St News
![Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News](https://cdn-news.warriortrading.com/wp-content/uploads/2017/07/19181628/PBYI.jpg)
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
![Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1181263174/image_1181263174.jpg?io=getty-c-crop-4-3)
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
![After making $1M+ on illegal trades, former Puma Biotechnology executive gets prison term | FiercePharma After making $1M+ on illegal trades, former Puma Biotechnology executive gets prison term | FiercePharma](https://qtxasset.com/fiercepharma/1529589242/law-1063249_1920.jpg/law-1063249_1920.jpg?VersionId=JwFDBshXeB7CRXl2SN8NwZZuYtcXFer2)